C81.41
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphocyte-rich Hodgkin lymphoma (HL) is a specific type of Hodgkin lymphoma that primarily affects lymph nodes in the head, face, and neck regions. This form of lymphoma is characterized by the presence of distinctive immune cells called lymphocytes within the affected lymph nodes. Although Hodgkin lymphoma can occur anywhere in the body, this particular subtype tends to present with localized symptoms in the upper body, making early detection and treatment important for favorable outcomes.
Causes & Symptoms
Clinical Causes: The exact cause of Hodgkin lymphoma remains unclear, but it is believed to involve genetic, environmental, and immune system factors. Infection with the Epstein-Barr virus (EBV) has been associated with a higher risk of developing Hodgkin lymphoma. Family history of Hodgkin lymphoma or other lymphatic cancers may increase susceptibility. Exposure to certain chemicals or toxins in occupational settings has been studied as potential risk factors.
Key Symptoms: Swelling or painless lumps in the lymph nodes of the head, face, or neck. Persistent sore throat or hoarseness. Difficulty swallowing or a feeling that something is caught in the throat. Unexplained weight loss. Fever and night sweats. Fatigue or general feeling of weakness. Recurrent infections or infections that are difficult to resolve.
Diagnostic & Treatment
Diagnosis Path: Diagnosing lymphocyte-rich Hodgkin lymphoma includes multiple steps:
Treatment Protocols: Chemotherapy: The main treatment for Hodgkin lymphoma involves chemotherapy regimens that target rapidly dividing cancer cells. Radiation therapy: Targeted radiation may be used in localized cases to eliminate remaining cancer cells after chemotherapy. Foundation therapies: Novel treatments, including immunotherapy agents, are increasingly becoming part of the treatment landscape. Supportive care: Managing symptoms and side effects, such as infections or blood count abnormalities, is vital during treatment. Follow-up monitoring: Regular medical assessments are crucial to detect any recurrence early.
Clinical Advice & FAQs
Billing Guidance
Is C81.41 a billable ICD-10 code?
Yes, C81.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.41?
Clinical documentation must specify the nature of Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference